Letter

Author's reply to criticism of study on benzodiazepines and risk of hip fracture

BMJ 2001; 323 doi: 10.1136/bmj.323.7315.752/a (Published 29 September 2001)
Cite this as: BMJ 2001;323:752.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Nicholas Moore (nicholas.moore@pharmaco.u-bordeaux2.fr), professor of clinical pharmacology
  1. Université Victor segalen-Bordeaux2, Bordeaux, France

    EDITOR—Sgadari et al's letter1 commented on the study that I and several others carried out to see whether benzodiazepines are associated with an increased risk of hip fracture.2 We found that they are not.

    In their large case-control study of 9752 patients with hip fractures compared with 38 564 controls, …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular